325 related articles for article (PubMed ID: 9951493)
1. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
Rahmani B; Jahadi HR
Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
[TBL] [Abstract][Full Text] [Related]
2. An analysis of risk for secondary hemorrhage in traumatic hyphema.
Rahmani B; Jahadi HR; Rajaeefard A
Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
[TBL] [Abstract][Full Text] [Related]
3. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
[TBL] [Abstract][Full Text] [Related]
4. Traumatic hyphema: outcomes of outpatient management.
Shiuey Y; Lucarelli MJ
Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid in the treatment of pediatric traumatic hyphema.
Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
[TBL] [Abstract][Full Text] [Related]
6. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and secondary bleeding after traumatic hyphema.
Marcus M; Biedner B; Lifshitz T; Yassur Y
Ann Ophthalmol; 1988 Apr; 20(4):157-8. PubMed ID: 3288070
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
9. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
Romano PE; Robinson JA
Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
[TBL] [Abstract][Full Text] [Related]
10. The incidence of rebleeding in traumatic hyphema.
Witteman GJ; Brubaker SJ; Johnson M; Marks RG
Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
12. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol.
Romano PE; Phillips PJ
Binocul Vis Strabismus Q; 2000; 15(2):187-96. PubMed ID: 10893462
[TBL] [Abstract][Full Text] [Related]
13. Outpatient management of traumatic hyphemas in children.
Coats DK; Viestenz A; Paysse EA; Plager DA
Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
[TBL] [Abstract][Full Text] [Related]
14. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
[TBL] [Abstract][Full Text] [Related]
15. Opposition to treatment of traumatic hyphema with antifibrinolytics/steroids.
Romano PE; Smith RJ
Binocul Vis Strabismus Q; 2000; 15(2):163-5. PubMed ID: 10893458
[No Abstract] [Full Text] [Related]
16. Oral administration of tranexamic acid in the management of traumatic hyphema in children.
Deans R; Noël LP; Clarke WN
Can J Ophthalmol; 1992 Jun; 27(4):181-3. PubMed ID: 1633590
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
[TBL] [Abstract][Full Text] [Related]
19. Aminocaproic acid prophylaxis in traumatic hyphema.
Wilson TW; Jeffers JB; Nelson LB
Ophthalmic Surg; 1990 Nov; 21(11):807-9. PubMed ID: 2270168
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
